Tweenvest Stocks

Global X Funds - Global X Genomics & Biotechnology ETF (NasdaqGM: GNOM)

Financials · Capital Markets · US

$58.31

+0.23% today · +57.6% 1Y

Global X Funds - Global X Genomics & Biotechnology ETF (NasdaqGM: GNOM) operates in the Capital Markets industry within the Financials sector. The company is valued at $85.41M.

Over the last twelve months the share price has gained 57.6%, trading between 34.69 and 59.48.

Tweenvest scores Global X Funds - Global X Genomics & Biotechnology ETF across four factors: dividend 26/100. Its strongest factor is dividend.

GNOM price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$85.41M
Revenue (TTM)
P/E
EPS
Dividend yield
1.11%
Beta (5Y)
1.17
52-week high
$59.48
52-week low
$34.69
Avg volume (3M)
Shares outstanding
1.46M
Employees
Next earnings

About Global X Funds - Global X Genomics & Biotechnology ETF

The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.

ISIN
US37960A2143
Founded
2019
Listed since
Apr 10, 2019
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI$2.31T$378.15+0.29%
Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO$1.67T$704.02+0.31%
iShares Trust - iShares Core S&P 500 ETFARCA: IVV$892.30B$769.62+0.32%
State Street SPDR S&P 500 ETF TrustARCA: SPY$811.28B$765.91+0.32%
Invesco QQQ Trust, Series 1NasdaqGM: QQQ$483.79B$710.72+0.62%
Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG$378.70B$87.40+0.54%
Morgan StanleyNYSE: MS$340.45B$216.53-0.11%
The Goldman Sachs Group, Inc.NYSE: GS$320.59B$1,060.19+0.12%

Browse every Capital Markets company →

Figures last refreshed Aug 18, 2026.